Clinical trial of adjuvant therapy combination shows improved recurrence-free survival in liver cancer patients at high-risk of recurrence.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Source:
    Immunotherapy Weekly; 11/07/2023, p253-253, 1p